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Abstract
Background: The objective of this study was to examine the extent of surgical procedures,
pathological findings, complications and outcome of patients treated in the last 12 years for
gallbladder cancer.
Methods: The impact of a standardized more aggressive approach compared with historical
controls of our center with an individual approach was examined. Of 53 patients, 21 underwent
resection for cure and 32 for palliation.
Results: Overall hospital mortality was 9% and procedure related mortality was 4%. The
standardized approach in UICC stage IIa, IIb and III led to a significantly improved outcome
compared to patients with an individual approach (Median survival: 14 vs. 7 months, mean+/-SEM:
26+/-7 vs. 17+/-5 months, p = 0.014). The main differences between the standardized and the
individual approach were anatomical vs. atypical liver resection, performance of systematic lymph
dissection of the hepaticoduodenal ligament and the resection of the common bile duct.
Conclusion: Anatomical liver resection, proof for bile duct infiltration and, in case of tumor
invasion, radical resection and lymph dissection of the hepaticoduodenal ligament are essential to
improve outcome of locally advanced gallbladder cancer.
Background
In the recent surgical literature therapy of gallbladder can-
cer (GC), which has traditionally been viewed with thera-
peutic nihilism, has documented an increase of 5 year
survival rates from 5–12% up to 38% [1]. Because the sur-
vival of patients treated by palliative chemotherapy or
radiation is poor, limited to months, an aggressive
approach to locally confined disease is justified. However,
there is considerable controversy what exactly constitutes
that "aggressive surgical approach" [2]. The armamentar-
ium of surgical procedures mainly comprised liver resec-
tion, common bile duct resection, lymph node dissection
in the hepaticoduodenal ligament and -especially prac-
ticed in Japan- concomitant pancreatoduodenectomy or
lymph dissection of the interaortocaval compartment.
With respect to the liver resection, the variety of proce-
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anatomical parenchyma sparing segment IVb/V resections
up to extended right or left hemi-hepatectomies. The indi-
cations for several procedures depend more on center spe-
cific algorithms than on randomized trials. In our
department there was a switch in March 2001 to a more
aggressive surgical approach in the treatment of gallblad-
der cancer with a standardized approach comprising ana-
tomical segment IV (round ligament approach resection)/
segment V resection, systematic lymph dissection of the
hepaticoduodenal ligament (HL) and resection of the
common bile duct (CBD) to reach tumor free margins.
Before March 2001, the surgical approach to gallbladder
cancer was largely dependent on the individual surgeon's
decision. The aim of this study was to examine the extent
of resection, the complication rate, the intraoperative and
microscopic findings and at least survival rates of patients
treated in the time period of the last 12 years with special
respect to the impact of the standardized approach on
outcome.
Patients and methods
Patients seen at the Department of General Surgery of the
University Hospital of the Saarland from November 1994
to January 2006 with the histologically proven diagnosis
of GC were identified from the national tumor registry,
the admission diagnosis and surgical procedures data
bank. Data were collected retrospectively from chart
review including operation reports and histological exam-
ination and survival time was calculated after telephone
interviews with patients or practitioners of the patients.
All patients with a curative or a palliative surgical inten-
tion were included, as well as patients reoperated for
recurrent GC.
After median laparotomy and exclusion of distant metas-
tases (e.g. liver metastases or peritoneal seeding) cholecys-
tectomy (CHE) with frozen section of the macroscopically
unsuspicious cystic duct was performed. Whenever tumor
infiltration in the gallbladder bed of the liver or the CBD
was suspected from preoperative radiological examina-
tions or the intraoperative macroscopic aspect we
intended to perform an en bloc resection of the gallbladder
together with segment IVb/V resection or with CBD resec-
tion. In cases of previous CHE the cystic duct was identi-
fied and a frozen section was also examined from the
resection margin. The next step was the incision of the
lesser omentum followed by a lymph dissection from the
left gastric artery to the celiac trunk as well as lymph dis-
section from the common hepatic artery until the
branches of the right and left hepatic artery (LN 7, 8a, 8p,
9, 12). Then the lymph nodes between the portal vein and
the CBD were resected (LN 12p, 13a). In case of bile duct
infiltration the CBD was transected just above the pancre-
atic border and was resected en bloc with the lymphatic
tissue of the HL and the dorsopancreatic lymph nodes
after the Köcher's procedure until the right border of the
aorta (LN 13 b). After that the bifurcation of the hepatic
duct was mobilized by lowering the hilar plate. From the
hilar transaction of the common hepatic bile duct also a
frozen section was performed to prove for tumor free
resection margins. After the transaction of the bile duct
and the lymph dissection liver resection of the gallbladder
bed (Couinaud segments IVb and V) was done using the
round ligament approach and selective clamping of the
anterior pedicle of the right portal vein. After devasculari-
zation of the vessels the liver bed became demarcations
(figure 1) and the liver parenchyma was resected anatom-
ically along this margin with the use of an ultrasound dis-
sector as well as vascular clips and PDS 4/0 sutures of
major vessels and bile ducts (figure 2). Blood coagulation
was additionally achieved by argon beamer coagulation
and the use of tachosil®. After common hepatic bile duct
resection hepaticojejunostomy was performed with a
transmesocolic lifted jejunal loop. Intestinal continuity
was achieved with a Roux en Y side-to-end anastomosis.
When the tumors infiltrated neighboring organs (espe-
cially the right colonic flexure) an en bloc resection was
performed to achieve complete histological removal of
the tumor at the resection margins (R0). In cases of previ-
ous laparoscopic CHE excision of the port site where the
gallbladder was removed was done at the end of the pro-
cedure.
As no lymph node metastases and a good survival were
reported in T1a tumors [3] simple CHE was considered as
adequate radical for this group. In contrast, in patients
Gallbladder cancer infiltrating the liverFigure 1
Gallbladder cancer infiltrating the liver. En bloc resection of 
the tumor mass with liver segments IVb and V. Arrows dem-
onstrate demarcation of segment IVb after round ligament 
approach.Page 2 of 8
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ing to the findings of the French Surgical Association Sur-
vey [4].
The survival rates were estimated and plots constructed by
the Kaplan-Meier method with the aid of a statistic soft-
ware (SigmaStat 3.0®, SPSS). Tumors were staged accord-
ing the TNM-classification and the actual classification of
the International Union Against Cancer (UICC) [5]. Dif-
ferences among the survival rates were compared with the
log-rank test. A p-value of less than 0.05 was considered
significant. Numerical data were expressed as mean ±
standard deviation for normal distributed and as median
with range for non-normal distributed values. Differences
of mean values were compared with the student t-test and
for median values with the Mann-Whitney-U-test.
Results
Demographics
Fifty three patients with GC were identified. Thirty nine
were female and fifteen male, with an average age at first
presentation of 67 (39–88) years. Median hospital stay
was 15 (3–77) days. Twenty one patients were operated
with a curative intention. Of these seventeen patients had
undergone previous CHE and were reoperated. In the
remaining patients there was only a palliative procedure
possible due to advanced tumor stages with distant metas-
tases, recurrent disease or because of significant medical
co morbidity. About half of the patients in palliative ther-
apy group underwent staging laparotomy (n = 14) or
laparoscopy (n = 1). In eight patients reoperation due to
recurrent disease was performed. Even when tumor resec-
tion was performed in this group, the operation was con-
sidered as palliative. In the remaining patients varying
palliative procedures were performed ranging from cyro-
therapy of liver metastases to implantation of a venous
port system for palliative chemotherapy. In three patients
bypass surgery was done, two patients with gastroduode-
nal stenosis received gastroenterostomy and in one
patient with colonic infiltration of the right flexure
received ileotransversostomy.
Disease stage
In Table 1 the UICC stages of the GCs and the percentage
of R0-resections is shown. There was a large proportion of
R0 resections after implementation of the standardized
approach even in patients with lymph node metastasis
and in tumors infiltrating two neighbored tissues. How-
ever, no curative resection was possible in stage IV patients
and also the chance for curative resection in recurrent dis-
ease was quite low.
Recurrent disease
During the study period of 12 years we treated 8 patients
with recurrent disease of GC (Table 2). One half of the
patients had undergone CHE in another hospital previ-
ously, the other half was treated in our department from
the beginning. The most marked finding was that no dis-
section of the HL was performed in three fourths (6/8) of
the patients, especially in the patient without completion
operation after CHE with histological diagnosis of GC,
who developed the tumor behind the HL. Another prob-
lem was that tumor free resection margins could not be
achieved in one patient who developed early gastric sten-
osis. Half of the patients with recurrent disease underwent
non-anatomical resection. However, tumor recurrence
was also seen in four patients after anatomical segment
IVb/V liver resection.
Operative procedures and histological findings
To examine the tumor spread in relation to the tumor
state histological findings of all operated patients (cura-
tive as well as palliative) were analyzed (Table 3). As not
in every case complete resection of liver segments IVb/V,
lymph dissection of the HL and resection of CBD was per-
formed, the proportion of histologically proved tumor
infiltration in the resected specimens is documented in
parentheses. Additionally, the incidence of metastases
Well perfused liver after resection of segments IVb/V, with high intrahilar bilia y-intestinal anastomosis (arrow)Fi ure 2
Well perfused liver after resection of segments IVb/V, with 
high intrahilar biliary-intestinal anastomosis (arrow).
Table 1: Staging (UICC 2002 classification) and percentage of R0 
resection of the gallbladder cancers
Stage Number Percentage of R0 resections
I b 9 100%
II a 2 100%
II b 9 77%
III 6 66%
IV 19 0%
recurrent tumour 8 12%Page 3 of 8
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cating advanced lymphatic spread are shown. There was
only one T1b tumor with segment IVb/V liver resection
and lymph dissection of the HL and no evidence of liver
and lymph node infiltration. In eleven of 17 patients with
T2 tumors segment IVb/V liver resection was performed.
By definition, there was no liver infiltration found in this
group. However, in 25% of 13 resected lymphatic tissue
specimens of the HL there were signs of lymphatic spread.
Additionally there was an infiltration of the CBD in
already 25% of T2 tumors. In this study there were 17
patients with T3 tumors. Four of these 17 (24%) patients
had undergone open CHE previously and underwent the
completion operation. In only half of the patients of the
T3 group liver resection was performed, as there were
already signs of distant tumor spread like positive lymph
nodes at the celiac trunk or disseminated metastases
found. Finally, in T4 patients there was a tremendous high
incidence of distant or disseminated metastases and an
obligatory infiltration of the HL. In patients with dissem-
inated metastases liver resection was not indicated and
therefore there were also three patients with metastases
classified as Tx. In eight patients reoperated for comple-
tion operation after laparoscopic CHE the skin and soft
tissue of the port site was excised (data not shown). How-
ever, in no specimen of port sites tumor cells were found
by the pathologist.
In thirteen cases anatomical resection was performed, in
one case right sided hemihepatectomy and in remaining
10 patients non-anatomical liver resection (Table 4).
Mean intraoperative transfusion requirements of packed
red blood cells was 0.6 ± 0.3 units in the anatomical and
1.1 ± 0.9 units in the non-anatomical group. Eight
patients in the anatomical and eight patients in the non-
anatomical group did not need any intraoperative blood
transfusion. There was also only one patient in each group
needing administration of 5 or 4 fresh frozen plasma
intraoperatively. Time of the operation including lymph
dissection of the HL was also not different between ana-
tomical and non-anatomical liver resection.
Postoperative complications and mortality
A total of 30 of 53 patients had an uneventful postopera-
tive course during their hospital stay. There were some
minor complications like postoperative urinary tract
infection in one patient, delayed wound healing in one
patient, pleural effusion in 4 patients, pneumonia in 2
patients and prolonged intestinal atonia in 3 patients. In
three cases there was an anastomotic leakage of the hepa-
ticojejunostomy which made reoperation necessary. Two
of these patients developed liver abscess. Five patients
died during the hospital stay. Two deaths could be directly
related to the surgical procedure in one patient with post-
operative bleeding due to erosion of the hepatic artery
Table 2: Patients treated with recurrent disease after previous curative surgery for gallbladder cancer (n = 8).
Gender/Age 
[years]
TNM Procedure Time until 
reintervention 
[months]
Problem Palliative procedure Oucome
female,49 TxNxM0 non anatomical liver resection after 
previous open CHE, no lymph 
dissection, no exploration of CBD
22 icterus hepaticojejunostomy 40 months later alive
male, 69 T2NxM0 non anatomical liver resection after 
previous open CHE, no lymph 
dissection, no exploration of CBD
6 liver metastases seg. 
VII, tumour 
recurrence seg. IV/V
bisegmentectomy seg. IVb/V, 
cryotherapy seg. VII
died 4 months later
female,69 T2N1M0 non anatomical liver resection Seg. 
IVb after previous laparoscopic 
CHE, radical lymph dissection, 
excision of port sites and tumour 
free resection margins CBD
12 icterus seg. III-bypass, gastroenterostomy died 3 months later
male, 72 T2NxM0 T2 GBC after open CHE, no 
completion operation
23 tumour between 
hepaticoduodenal lig. 
and pancreas
exploration died 6 months later
female, 68 T3N1M0 anatomical liver resection Seg. IVb/
V after open CHE, lymph 
dissection, no tumour free 
resection margin CBD
3 gastric stenosis, liver 
abscess
interventional abscess drainage, 
implantation venous port system
died 1 month later
male, 64 T3NxM0 anatomical liver resection Seg. IVb/
V after open CHE, no lymph 
dissection, tumour free resection 
margin CBD
1 duodenal stenosis gastroenterostomy died 1 month later
female, 60 T3NxM0 bisegmentectomy seg. IVb/V en 
bloc with CHE, no lymph 
dissection tumour free resection 
margin of CBD,
11 skin metastasis resection died 13 months later
male, 74 T4NxM0 non-anatomical wedge resection of 
seg. IVb during CHE, no lymph 
dissection, no tumour free 
resection margin of CBD
2 tumour progress with 
liver infiltration
cryotherapy lost for follow up
Abbreviations: CHE = cholecystectomy, CBD = common bile duct, seg. = Couinaud liver segmentPage 4 of 8
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developed postoperative liver failure. Two other patients
died due to medical reasons (cardiac failure and pulmo-
nary embolism). Finally one patient died due to tumor
progress already during her hospital stay after staging
laparoscopy.
Survival
Median follow-up was 13 (0–51) months. To further clar-
ify the role of the standardized approach on survival all 21
patients with T1, T2 and T3 tumors, operated with cura-
tive intention (R0 resections), were divided the patients in
a group with standardized and individual resections
(Table 4). Standardized resection was defined as liver
resection, lymph dissection of the HL, exploration of the
CBD and (in case of tumor infiltration) resection until
tumor free resection margins are achieved. In the individ-
ual group one of these three components was not per-
formed due to the surgeons' individual decision.
Formally, the histological analyses of the resection speci-
mens revealed R0 resection, although there was no unique
information about the tumor infiltration of the gallblad-
der bed, the HL and the CBD. In most cases the deviation
of the individual approach compared with the standard
was that no lymph dissection of the HL was performed
and no frozen section of the cystic duct was performed to
exclude bile duct infiltration. Survival analysis of the
patients treated according the standardized approach
compared with patients treated according an individual
approach showed significant better survival for patients
undergoing standard resection with a median survival of
14 months compared to 7 months in individual resection
group (Figure 3).
Discussion
Until the last 10 years GC has always been associated with
dismal prognosis, due to the asymptomatic growth of the
tumor and finally the infiltration of the surrounding struc-
tures as the hepatic artery, the portal vein or the wide
spread lymph infiltration making a curative resection
impossible. In the retrospective analysis of the surgical
treatment of 724 patients with GC treated primarily in
Europe between 1980 and 1989 no progress has been
observed with respect to survival [4]. However, since the
Table 3: Operative procedures according to tumor staging (UICC 2002 classification).












T1b n = 1 1/1 (0%) 1/1 (0%) 0%
T2 n = 17 11/17 (0%) 13/17 (25%) 5/17 (0%) 4/17 (25%) 0%
T3 n = 14 7/14 (100%) 7/14 (67%) 2/14 (50%) 5/14 (40%) liver n = 1 peritoneal carcinosis n = 3
T4 n = 17 6/17 (100%) 4/17 (100%) 2/17 (100%) 0/17 liver n = 5, pancreas n = 1, lung n = 1, 
peritoneal carcinosis n = 6
Tx n = 4 0/4 0/4 0/4 liver n = 1, peritoneal carcinosis n = 2
Reported is first the number of patients who received the certain procedure and than the total number of patients with the certain tumor stage. In 
parentheses the percentage of histological proved tumor infiltration in the resection specimens is demonstrated.
Table 4: Demographic data for the Standardized and Individual approach in 21 patients treated with curative intention (R0 
resections).
Individual Approach n = 9 Standardized Approach n = 12
Age







Anatomical 2 (22%) 12 (100%)
Non-anatomical 6 (67%)
Lymphdissection
Hepaticoduodenal Ligament 6 (67%) 12 (100%)
CBD
Exploration/Resection* 1 (11%) 12 (100%)
In parentheses the percentage of the procedure in relation to the whole treatment group (n = 9 patients with individual and n = 12 patients with 
the standardized approach)Page 5 of 8
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hope for improvement of survival after an aggressive sur-
gical approach in resectable lesions [6-8]. This was espe-
cially relevant for tumors infiltrating the liver, the bile
duct or the lymphatic nodes. Whereas survival in T1a
tumors without infiltration of the muscle layer is generally
good and extended CHE (e.g. with wedge resection of the
gallbladder bed) is unlikely to improve the outcome in
this group, there is still a debate whether T1b tumors
(tumor invading through the mucosa into the muscle
layer) should be treated like T2 tumors and liver resection
combined with lymph dissection of the HL should be per-
formed [9]. In this study there was only one patient with
a T1b tumor, but we think that treatment in T1b tumors
should not differ from T2 tumors. Thereby we focus
mainly on the lymphatic spread of the tumor. It has been
shown that lymphatic spread occurs early, before liver
involvement and that nodal involvement is a poor prog-
nostic factor [10-14]. However, there were many patients
reported in the literature, in whom lymph node metas-
tases had been excised and who survived more than 5
years. Our finding of early involvement of the HL in GC
and an incidence of 25% in T2 tumors confirms these
reports. Lessons we learned from the course of our
patients presenting with recurrent tumors after intended
curative resections (see table 2) revealed that treatment
strategies in the past focused too much on liver infiltration
thereby forgetting the lymphatic spread. In the past, in our
department infiltration of the HL has not usually been an
indication for lymph dissection or was used as an argu-
ment against the feasibility of curative resection. The pre-
liminary report of the German CAE-S/CAMIC registry of
CHEs with a postoperative incidental finding of cancer
comprises about 245 patients with GC [14]. In the registry
there were 118 patients with T2 tumors, 44 patients with
T3 tumors and 20 patients with T4 tumors. Altogether,
there were only 70 reoperations performed. This demon-
strates that an aggressive surgical approach is still not per-
formed everywhere. One major problem in simple CHE is
that no definite statement about lymph node infiltration
can be done macroscopically and the tumor stage might
be underestimated. The missing of lymph node infiltra-
tion might result in progressive lymphatic tumor spread
especially into coeliacal, peripancreatic and interaorto-
caval lymphatic nodes leading to rapid and disseminated
tumor growth and dismal prognosis. Of importance, there
were therefore 70 patients in the CAE-S/CAMIC registry
with recurrent disease after a median follow-up of 27
months.
In this study we could demonstrate a better survival of R0-
resections in patients after the implementation of a stand-
ardized surgical approach for GC ranging from UICC
stage Ia (T1b tumors) to stage III (T4 tumors with and
without regional lymphatic node metastases). To our
opinion the marked difference of the standardized
approach in comparison to the individual resections, was
the radial dissection of the HL and the resection of the
CBD.
Before the implementation of the standard operation,
liver resection was usually performed as non-anatomical
wedge resection of the gallbladder bed to reach tumor free
resection margins. Although this study could not clarify
whether anatomic segmentectomy is superior to a non-
anatomic wedge resection, we nowadays advocate the
anatomical segment IVb/V liver resection with the selec-
tive extrahepatic vascular approach. By some authors right
sided hemihepatectomy is recommended to respect a
security distance of the tumor of about 3 cm. Ogura et al.
measured the distance between the front of the carcinoma
invasion and the resection plane in the hepatic paren-
chyma [15]. The distance ranged between 12–20 mm after
wedge resection, 16–35 mm after resections of segments
IV+V and 28–58 mm after extended hepatic resections. By
the analysis of the pathological reports of our liver resec-
tion specimen we found that a 3 cm distance can also be
achieved by 77% of segment IVb/V resections. Moreover
we demonstrate in this study that this procedure can usu-
ally be done without requiring blood transfusions. There-
fore segment IVb/V liver resection is a better alternative
than hemihepatectomy as it is sufficient in most cases to
Survival of curative resection of gallbladder carcinoma fol-lowing the standard op ration and with an indiv dual appro c  (formally RO resectio s, u  no rese tion of al  component  of th stand rd oper tion) (p < 0.014 log rank test)Figure 3
Survival of curative resection of gallbladder carcinoma fol-
lowing the standard operation and with an individual 
approach (formally RO resections, but no resection of all 
components of the standard operation) (p < 0.014 log rank 
test).Page 6 of 8
(page number not for citation purposes)
World Journal of Surgical Oncology 2007, 5:55 http://www.wjso.com/content/5/1/55achieve a R0 resection and is much less invasive. Only in
some cases of T4 tumors hemihepatectomy might be still
necessary to completely remove the tumor. Nevertheless,
radicality of resection is usually more dependent on
lymph dissection than resection of the infiltrated liver tis-
sue or surrounding organs like the small intestine and
colon.
Metastatic disease is usually no indication for surgery. In
this study we could not demonstrate any difference of
solid organ metastases compared to peritoneal tumor
seeding in terms of remaining survival time. There is also
no benefit of palliative CHE.
Whereas we are convinced of the benefit of the standard-
ized approach, some – primarily Japanese authors – advo-
cate the need of the resection of a "fourths or fifths
component", that is the necessity of the routine paraaortal
lymph node dissection or even the hepatopancreatoduo-
denectomy (HPD). Since the pioneer report of HPD by
Hanyu et al., [16] a large number of patients with UICC
stage III GCs was undergoing HPD and five year survival
rates from 29% – 87% were reported [17,18]. Despite the
evident pathoanatomical rational of this approach, as
there is a high incidence of peripancreatic infiltrated
lymph nodes, nearly all Western surgeons are hesitant to
pursue such an aggressive approach due to its high mor-
tality and morbidity.
Tsukada et al. found lymph node metastases in 12% of
patients who underwent paraaortic node dissection [3].
However, paraaortic lymphadenectomy provided no sur-
vival benefit and led to the same prognosis to that of dis-
tant metastases [19]. We did not routinely perform lymph
dissection in the interaortocaval compartment. In our
series we found every second lymph node biopsy at the
celiac trunk positive in T3 tumors and even every biopsy
positive in T4 tumors. But in the case of tumor infiltration
at the celiac trunk there were usually already metastases
detected, thus lymph dissection of the interaortocaval
compartment would have rarely been a real curative
option.
Conclusion
The standardized approach is an efficacious treatment for
locally advanced gallbladder carcinoma and did improve
survival compared to less aggressive surgical resections
even in our small cohort. In advanced tumor stages with
presence of peripancreatic lymph node disease a more
aggressive approach with HPD is limited by its high mor-
bidity. In metastatic disease, palliative surgical procedures
should be restricted to bypass measures like the segment
III bypass, gastroenterostomy or palliative intestinal resec-
tion to ensure quality of life. Our study should encourage
other centers to incorporate more aggressive standardized
procedures in the treatment of GC. Hopefully, this will
enable us to compare multicenter treatment results in the
future to better estimate the improvement in the surgical
therapy of the usually rare and prognostically serious GC.
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